Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen.

Autor: Barry, Houreratou^1,2 (AUTHOR), Lhomme, Edouard^2,3,4 (AUTHOR), Surénaud, Mathieu^4,5 (AUTHOR), Nouctara, Moumini¹ (AUTHOR), Robinson, Cynthia⁶ (AUTHOR), Bockstal, Viki⁶ (AUTHOR), Valea, Innocent^1,7 (AUTHOR), Somda, Serge^1,8 (AUTHOR), Tinto, Halidou^1,7 (AUTHOR), Meda, Nicolas^1,9 (AUTHOR), Greenwood, Brian¹⁰ (AUTHOR), Thiébaut, Rodolphe^2,3,4 (AUTHOR) Rodolphe.thiebaut@u-bordeaux.fr, Lacabaratz, Christine^4,5 (AUTHOR)

Publikováno v: PLoS Neglected Tropical Diseases. 4/11/2024, Vol. 18 Issue 4, p1-16. 16p.

Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso

Autor: Rouamba, Toussaint, Ouédraogo, Esperance, Barry, Houreratou, Yaméogo, Nobila Valentin, Sondo, Apoline, Boly, Rainatou, Zoungrana, Jacques, Ouédraogo, Abdoul Risgou, Tahita, Marc Christian, Poda, Armel, Diendéré, Arnaud Eric, Ouedraogo, Abdoul-Salam, Valea, Innocent, Traoré, Isidore, Tarnagda, Zekiba, Drabo, Maxime K, Tinto, Halidou

Publikováno v: In International Journal of Infectious Diseases May 2022 118:224-229

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial.

Autor: Anywaine, Zacchaeus¹ (AUTHOR), Barry, Houreratou² (AUTHOR), Anzala, Omu³ (AUTHOR), Mutua, Gaudensia³ (AUTHOR), Sirima, Sodiomon B.⁴ (AUTHOR), Eholie, Serge⁵ (AUTHOR), Kibuuka, Hannah⁶ (AUTHOR), Bétard, Christine⁷ (AUTHOR), Richert, Laura^7,8 (AUTHOR), Lacabaratz, Christine^8,9 (AUTHOR), McElrath, M. Juliana¹⁰ (AUTHOR), De Rosa, Stephen C.¹⁰ (AUTHOR), Cohen, Kristen W.¹⁰ (AUTHOR), Shukarev, Georgi¹¹ (AUTHOR), Katwere, Michael¹¹ (AUTHOR), Robinson, Cynthia¹¹ (AUTHOR), Gaddah, Auguste¹² (AUTHOR), Heerwegh, Dirk¹² (AUTHOR), Bockstal, Viki¹¹ (AUTHOR), Luhn, Kerstin¹¹ (AUTHOR)

Publikováno v: PLoS Medicine. 1/11/2022, Vol. 18 Issue 1, p1-18. 18p. 1 Diagram, 1 Chart, 2 Graphs.

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.

Autor: Barry, Houreratou¹ (AUTHOR), Mutua, Gaudensia² (AUTHOR), Kibuuka, Hannah³ (AUTHOR), Anywaine, Zacchaeus⁴ (AUTHOR), Sirima, Sodiomon B.⁵ (AUTHOR), Meda, Nicolas¹ (AUTHOR), Anzala, Omu² (AUTHOR), Eholie, Serge⁶ (AUTHOR), Bétard, Christine⁷ (AUTHOR), Richert, Laura^7,8 (AUTHOR), Lacabaratz, Christine^8,9 (AUTHOR), McElrath, M. Juliana¹⁰ (AUTHOR), De Rosa, Stephen¹⁰ (AUTHOR), Cohen, Kristen W.¹⁰ (AUTHOR), Shukarev, Georgi¹¹ (AUTHOR), Robinson, Cynthia¹¹ (AUTHOR), Gaddah, Auguste¹² (AUTHOR), Heerwegh, Dirk¹² (AUTHOR), Bockstal, Viki¹¹ (AUTHOR), Luhn, Kerstin¹¹ (AUTHOR)

Publikováno v: PLoS Medicine. 10/29/2021, Vol. 18 Issue 10, p1-22. 22p. 3 Charts, 3 Graphs.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.